CEO Patrick Spearman said he expects the FDA to grant Envoy’s Premarket Approval (PMA) application by next February. Although FDA advisory panel recommendations are not binding, the agency almost always follows them.
[Read more of this report]
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Merrill GooznerPharma, device firms kill conflict of interest rule, win accelerated approval
Dr. John D. HalamkaBYOD makes mobile security more complicated
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Amy SiegelTop 5 anxiety-provoking medtech acronyms
Stephen Schimpff MDIntegrative Medicine Part II — Health Care of the Future
John Mandrola, MDWeighing the risks of Pradaxa vs. the risk of stroke